Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Lancet. Microbe|November 9, 2021
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trialMohammad Bosaeed, Hanan H Balkhy, Sultan Almaziad, et al.The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trialPedro M Folegatti, Mustapha Bittaye, Amy Flaxman, et al.JAMA|April 20, 2016
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical TrialIain D Milligan, Malick M Gibani, Richard Sewell, et al.Cell Reports|May 4, 2023
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccinationZixi Yin, Ji-Li Chen, Yongxu Lu, et al.NPJ Vaccines|February 6, 2025
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01EM Sanni Ali, Lisa Stockdale, Issaka Sagara, et al.Plos One|September 8, 2021
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adultsMarvin J Sklar, Santina Maiolatesi, Noelle Patterson, et al.Nature Medicine|May 13, 2024
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine responseAlexander J Mentzer, Alexander T Dilthey, Martin Pollard, et al.The New England Journal of Medicine|January 29, 2015
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAKatie Ewer, Tommy Rampling, Navin Venkatraman, et al.Pageof 4